RenovaCare Inc (RCAR) Stock Price, Trades & News

RenovaCare Inc is a biotechnology company focusing on the acquisition, research, development and commercialization of autologous cellular therapies that can be used for medical and aesthetic applications. The company's initial products under development target skin. It offers treatment methodology for cell isolation for the regeneration of human skin cells, along with a medical-grade liquid spraying device and associated equipment (the SkinGun). RenovaCare is evaluating the efficacy and potential of SkinGun, in combination with a cell isolation method, in the treatment of tissue that has been subject to severe trauma. Geographically all the activities are functioned through the region of United States.

Financial Strength

	Name	Current	Vs Industry		Vs History

Growth Rank

	Name	Current	Vs Industry		Vs History

Momentum Rank

	Name	Current	Vs Industry		Vs History

Liquidity Ratio

	Name	Current	Vs Industry		Vs History

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History

Profitability Rank

	Name	Current	Vs Industry		Vs History

GF Value Rank

	Name	Current	Vs Industry		Vs History

Financials (Next Earnings Date:2026-06-30 Est.)

Annual Quarterly TTM

RCAR's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Guru Trades

See Details

Insider Trades

See Details

Gurus Latest Trades with OTCPK:RCAR

No Available Data

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

RenovaCare Inc Executives

Details

GF Value™

RCAR

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected issues with RCAR. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil $)
	EPS (TTM) ($)	-0.065
	Beta	-295.6293
	3-Year Sharpe Ratio	0.57
	3-Year Sortino Ratio	122.18
	Volatility %	-
	14-Day RSI	-
	14-Day ATR ($)	-
	20-Day SMA ($)	0.0001
	12-1 Month Momentum %	-
	52-Week Range ($)	0.0001 - 0.0001
	Shares Outstanding (Mil)	87.35

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	0
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

RenovaCare Inc Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

RenovaCare Inc Stock Events

Financials Calendars

Event	Date	Price ($)
Third quarter earnings results for 2026	2026-11-13	In 138 days
Second quarter earnings results for 2026	2026-08-14	In 47 days
First quarter earnings results for 2026	2026-06-30	In 2 days
General meeting for 2025	2026-06-29	In 1 day

Show

Entries

RenovaCare Inc Frequently Asked Questions

What is RenovaCare Inc(RCAR)'s stock price today?

The current price of RCAR is $0.00. The 52 week high of RCAR is $0.00 and 52 week low is $0.00.

When is next earnings date of RenovaCare Inc(RCAR)?

The next earnings date of RenovaCare Inc(RCAR) is 2026-06-30 Est..

Does RenovaCare Inc(RCAR) pay dividends? If so, how much?

RenovaCare Inc(RCAR) does not pay dividend.

Guru Commentaries on OTCPK:RCAR

No articles.

Press Release

	Subject	Date
	RM LAW Announces Investigation of RenovaCare, Inc.	2022-02-03
	RCAR Long-Term Investor Alert: Did You Acquire RenovaCare, Inc. Before August 14, 2017? Should Management be Held Accountable for Investors Losses?	2021-09-16
	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in RenovaCare, Inc. of Class Action Lawsuit and Upcoming Deadline - RCAR	2021-09-13
	Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against RenovaCare, Inc. (RCAR)	2021-09-10
	Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against RenovaCare, Inc. (RCAR)	2021-09-08
	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in RenovaCare, Inc. of Class Action Lawsuit and Upcoming Deadline - RCAR	2021-09-05
	RCAR 13-DAY DEADLINE ALERT: Hagens Berman Encourages RenovaCare (RCAR) Investors to Contact Firm's Attorneys Now, Deadline Approaching in Securities Fraud Class Action	2021-09-01
	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in RenovaCare, Inc. of Class Action Lawsuit and Upcoming Deadline - RCAR	2021-08-27
	RCAR INVESTOR ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages RenovaCare, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - RCAR	2021-08-26
	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in RenovaCare, Inc. of Class Action Lawsuit and Upcoming Deadline - RCAR	2021-08-19

10/Page

Articles on RenovaCare Inc

No articles.

Headlines

No news.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.